Mosquirix, malaria vaccine 30 years in the making, is being used in a pilot program for children under the age of 5 in Ghana, Malawi, and Kenya.
Malaria is one of the world’s deadliest and most stubborn diseases. The mosquito-borne disease kills more than 400,000 people every year. Two-thirds are children are under age 5, and most are in Africa.
Now, babies in three nations in Africa are getting the first vaccine for malaria in an unusual pilot program
Health officials want to see how well the vaccine works in Malawi, Ghana and Kenya before recommending wider use.
Unlike established vaccines that offer near-complete protection, Mosquirix, is only about 40% effective. Experts say it’s worth a try as progress in fighting malaria stalls.